Signal detection for statin-associated muscular adverse events.
N: the number of co-occurrences.
CI: the confidence interval; two-sided for ROR and IC, and one-sided for EBGM.
*: signal detected, see “Methods” for the criteria of detection.
Myalgia, rhabdomyolysis and increase of creatine phosphokinase (CPK) level were coded as PT10028411, PT10039020 and PT10005470, respectively.